Standard
Targeting anti-cancer drug resistance in gastro-intestinal cancer : Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump. / Ladekarl, M.; Schou, J. H. V.; Roest, N. L.; Stenvang, J.; Brunner, N.; Vestlev, P. M.
2020. S503-S504 Abstract from ESMO Virtual Congress.
Research output: Contribution to conference › Conference abstract for conference › Research
Harvard
Ladekarl, M, Schou, JHV, Roest, NL
, Stenvang, J, Brunner, N & Vestlev, PM 2020, '
Targeting anti-cancer drug resistance in gastro-intestinal cancer: Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump', ESMO Virtual Congress,
19/09/2020 -
18/10/2020 pp. S503-S504.
https://doi.org/10.1016/j.annonc.2020.08.719APA
Ladekarl, M., Schou, J. H. V., Roest, N. L.
, Stenvang, J., Brunner, N., & Vestlev, P. M. (2020).
Targeting anti-cancer drug resistance in gastro-intestinal cancer: Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump. S503-S504. Abstract from ESMO Virtual Congress.
https://doi.org/10.1016/j.annonc.2020.08.719Vancouver
Ladekarl M, Schou JHV, Roest NL
, Stenvang J, Brunner N, Vestlev PM.
Targeting anti-cancer drug resistance in gastro-intestinal cancer: Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump. 2020. Abstract from ESMO Virtual Congress.
https://doi.org/10.1016/j.annonc.2020.08.719Author
Ladekarl, M. ; Schou, J. H. V. ; Roest, N. L. ; Stenvang, J. ; Brunner, N. ; Vestlev, P. M. / Targeting anti-cancer drug resistance in gastro-intestinal cancer : Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump. Abstract from ESMO Virtual Congress.2 p.
Bibtex
@conference{3ec10ab0aed74d16a7d0ca79792b1711,
title = "Targeting anti-cancer drug resistance in gastro-intestinal cancer: Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump",
author = "M. Ladekarl and Schou, {J. H. V.} and Roest, {N. L.} and J. Stenvang and N. Brunner and Vestlev, {P. M.}",
year = "2020",
month = sep,
doi = "10.1016/j.annonc.2020.08.719",
language = "English",
pages = "S503--S504",
note = "ESMO Virtual Congress ; Conference date: 19-09-2020 Through 18-10-2020",
}
RIS
TY - ABST
T1 - Targeting anti-cancer drug resistance in gastro-intestinal cancer
T2 - ESMO Virtual Congress
AU - Ladekarl, M.
AU - Schou, J. H. V.
AU - Roest, N. L.
AU - Stenvang, J.
AU - Brunner, N.
AU - Vestlev, P. M.
PY - 2020/9
Y1 - 2020/9
U2 - 10.1016/j.annonc.2020.08.719
DO - 10.1016/j.annonc.2020.08.719
M3 - Conference abstract for conference
SP - S503-S504
Y2 - 19 September 2020 through 18 October 2020
ER -
